Glutamate monitoring in vitro and in vivo: recent progress in the field of glutamate biosensors

Medicine & Life Sciences

• Alzheimer Disease 4%
• Amyotrophic Lateral Sclerosis 6%
• Biosensing Techniques 100%
• Brain 3%
• Cell Death 4%
• Central Nervous System 9%
• Cognition 4%
• Enzymes 3%
• Equipment and Supplies 3%
• Fluorescence 5%
• Glutamic Acid 72%
• Huntington Disease 7%
• In Vitro Techniques 5%
• Learning 4%
• Memory 4%
• Microdialysis 14%
• Nanoparticles 5%
• Nanotechnology 7%
• Nanotubes 8%
• Nanowires 10%
• Neurodegenerative Diseases 5%
• Neurotransmitter Agents 5%
• Parkinson Disease 5%
• Stroke 4%
• Synaptic Transmission 5%